Exousia Bio (LMMY) Depreciation & Amortization (CF) (2022 - 2025)

Exousia Bio has disclosed Depreciation & Amortization (CF) across 4 years of filings, most recently posting $3775.0 for Q2 2025.

• Depreciation & Amortization (CF) for Q2 2025 came in at $3775.0, up 200.08% year-over-year; the trailing twelve-month figure through Nov 2025 was $3775.0 (down 24.98% YoY), and the FY2025 annual result was $3775.0, down 25.0% from the prior year.
• Depreciation & Amortization (CF) came in at $3775.0 for Q2 2025 at Exousia Bio, up from $1258.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $3775.0 in Q2 2025 to a low of $1258.0 in Q3 2022.
• The 4-year median for Depreciation & Amortization (CF) is $1258.0 (2022), against an average of $1486.9.
• Across the five-year window, Depreciation & Amortization (CF) dropped 0.08% in 2023 and jumped 200.08% in 2025, its largest moves.
• Exousia Bio's Depreciation & Amortization (CF) stood at $1259.0 in 2022, then fell by 0.08% to $1258.0 in 2023, then changed by 0.0% to $1258.0 in 2024, then surged by 200.08% to $3775.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $3775.0 (Q2 2025), $1258.0 (Q4 2024), and $1258.0 (Q3 2024), per Business Quant data.